International Clinical Trial: Efficacy of Diloxanide Furoate as Additional Luminal Agent Along With Metronidazole for the Treatment of Amoebic Liver Abscess

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07807150) titled 'Efficacy of Diloxanide Furoate as Additional Luminal Agent Along With Metronidazole for the Treatment of Amoebic Liver Abscess' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh

Condition: Liver Abscess Amoebic Liver Abscess

Intervention: Drug: Diloxanide furoate

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: September 4, 2026

Target Sa...